These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16462825)

  • 1. Glioblastoma--more questions than answers?
    Reardon DA
    Nat Clin Pract Oncol; 2006 Feb; 3(2):60-1. PubMed ID: 16462825
    [No Abstract]   [Full Text] [Related]  

  • 2. Carmustine wafers (Gliadel) plus concomitant temozolomide therapy after resection of malignant astrocytoma: growing evidence for safety and efficacy.
    McGirt MJ; Brem H
    Ann Surg Oncol; 2010 Jul; 17(7):1729-31. PubMed ID: 20422453
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy in glioblastomas: false steps and real advances.
    Brandes AA; Tosoni A; Franceschi E
    Expert Rev Anticancer Ther; 2007 May; 7(5):607-8. PubMed ID: 17492923
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.
    Lillehei KO; Kalkanis SN; Liau LM; Mydland DE; Olson J; Paleologos NA; Ryken T; Johnson T; Scullin E
    CNS Oncol; 2018 Apr; 7(2):CNS08. PubMed ID: 29206049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology 2011 CNS tumors update.
    Ahluwalia MS
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1495-7. PubMed ID: 21999122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical oncology: treatment and management of malignant gliomas.
    Park DM; Sathornsumetee S; Rich JN
    Nat Rev Clin Oncol; 2010 Feb; 7(2):75-7. PubMed ID: 20118976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results for Treatment of Newly-Diagnosed Glioblastoma Using Carmustine Wafers(Gliadel
    Kumabe T; Shibahara I; Saito R
    No Shinkei Geka; 2018 May; 46(5):367-376. PubMed ID: 29794312
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
    Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide.
    O'Toole L; Khanduri S; Gerrard GE
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):269. PubMed ID: 17433972
    [No Abstract]   [Full Text] [Related]  

  • 11. Nomograms as clinicobiological predictors of survival in glioblastoma.
    Bredel M
    Lancet Oncol; 2008 Jan; 9(1):5-6. PubMed ID: 18177813
    [No Abstract]   [Full Text] [Related]  

  • 12. O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.
    Balaña C; Ramirez JL; Taron M; Roussos Y; Ariza A; Ballester R; Sarries C; Mendez P; Sanchez JJ; Rosell R
    Clin Cancer Res; 2003 Apr; 9(4):1461-8. PubMed ID: 12684420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [II. Current status of BCNU stent in the brain for treatment of glioma].
    Aoki T; Yamada S
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):708-17. PubMed ID: 23957061
    [No Abstract]   [Full Text] [Related]  

  • 14. [Local antitumor treatments].
    Menei P; Metellus P
    Neurochirurgie; 2010 Dec; 56(6):483-5. PubMed ID: 20869735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor treating fields therapy for recurrent glioblastoma.
    Manag Care; 2012 Dec; 21(12):43-4. PubMed ID: 23304737
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective study on glioblastoma in the elderly.
    Brandes AA; Vastola F; Basso U; Berti F; Pinna G; Rotilio A; Gardiman M; Scienza R; Monfardini S; Ermani M
    Cancer; 2003 Feb; 97(3):657-62. PubMed ID: 12548608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is protracted low-dose temozolomide feasible in glioma patients?
    Wong ET
    Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.
    Linassier C; Benboubker L; Velut S; Calais G; Saudeau D; Jan M; Autret A; Berger C; Biron P; Colombat P
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S69-72. PubMed ID: 8899180
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of polyanhydrides for drug delivery applications.
    Tamada J; Langer R
    J Biomater Sci Polym Ed; 1992; 3(4):315-53. PubMed ID: 1350734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
    Pitini V; Arrigo C; Righi M
    Cancer; 2004 Dec; 101(12):2900-1; author reply 2901-2. PubMed ID: 15529311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.